Clinical Research Directory
Browse clinical research sites, groups, and studies.
Campylobacter Spp. Bone and Joint Infection: a Retrospective Cohort Study
Sponsor: Hospices Civils de Lyon
Summary
Campylobacter bacteria, a Gram-negative bacillus commensal in the digestive tract of many animals and mainly responsible for human infections with digestive origins, has been little studied in the field of osteoarticular infections (OAI). Campylobacter spp. are, however, well described, mainly for C. fetus, and pose a dual therapeutic problem: i) a capacity for persistence due to the capacity of most strains to form biofilm; and ii) potential resistance to many antibiotics. The management of IOA caused by Campylobacter spp. is not codified, and is based on small series of cases reported in the literature.
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2024-01-01
Completion Date
2024-06-30
Last Updated
2024-05-22
Healthy Volunteers
No
Conditions
Interventions
Management, progression and risk factors for failure of BJI caused by Campylobacter spp.
Description of demographic data (sex, age), comorbidities (ASA and Charlson scores), orthopedic and septic history, and surgical and medical management (antibiotic therapy)
Description of the evolution and risk factors for failure of osteoarticular infections caused by Campylobacter spp.
Failure of treatment: defined according to a composite criterion bringing together * persistence of the infection under treatment, and/or * recurrence of the infection after stopping antibiotic therapy, and/or * need for surgical revision for septic reasons more than 5 days after initial treatment, and/or * superinfection, and/or * definitive explantation of the material, and/or * decision for suppressive antibiotic therapy, and/or * amputation, and/or * death linked to infection
Locations (1)
Service des maladies infectieuses et tropicales - Hôpital de la Croix-Rousse
Lyon, France